Clinical Trials in Salt Lake City

Showing 2221-2240 of 7,997 trials

Conservative Management for PAS Pilot

NCT05139498

Conservative in situ management is a promising alternative treatment to hysterectomy for patients with placenta accreta spectrum and may be safer and preferable for some patients. This study will assess feasibility of a future randomized clinical trial comparing these treatments and provide novel data to inform shared decision-making and cost-effective care for patients with this deadly pregnancy disorder.

Placenta Accreta

University of Utah32 participantsStarted May 2022

Salt Lake City, Utah, United States

RECRUITINGPhase 3< 1 mile

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

NCT06112990

The goal of this clinical trial is to test the use of creatine monohydrate supplementation with resistance training to preserve muscle mass and help lessen prostate cancer progression. The main question it aims to answer is if this treatment will help maintain muscle mass to help in reducing fatigue and improving physical function, independence, and quality of life. Participants will be asked to participate in a 52-week exercise intervention consisting of a twice weekly telehealth resistance training program.

Metastatic Prostate Cancer

University of Utah200 participantsStarted Nov 2023

Salt Lake City, Utah, United States

Conservative Management for PAS Pilot

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

Find Trials by Condition in Salt Lake City

Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors

Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

Ureteral Stent Placement After Ureteroscopy for Renal Stones: A Randomized Controlled Trial

Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Pramipexole to Enhance Social Connections